Maderer, A.; Goepfert, K.; Sauvigny, D. et al.
EL102-a new strategy for targeting hypoxia-driven cancerONCOLOGY RESEARCH AND TREATMENT. Bd. 37. 2014 S. 32-32
Schachschal, Guido; Mayr, Michael; Treszl, Andras et al.
Endoscopic versus histological characterisation of polyps during screening colonoscopyGUT. Bd. 63. H. 3. 2014 S. 458-465
Raggi, Chiara; Factor, Valentina M.; Seo, Daekwan et al.
Epigenetic Reprogramming Modulates Malignant Properties of Human Liver CancerHEPATOLOGY. Bd. 59. H. 6. 2014 S. 2251-2262
Thomaidis, Thomas; Weinmann, Arndt; Sprinzl, Martin et al.
Erythropoietin treatment in chemotherapy-induced anemia in previously untreated advanced esophagogastric cancer patientsINTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY. Bd. 19. H. 2. 2014 S. 288-296
Sivanathan, V.; Kittner, J. M.; Sprinzl, M. F. et al.
Etiology and complications of liver cirrhosis: data from a German centreDEUTSCHE MEDIZINISCHE WOCHENSCHRIFT. Bd. 139. H. 36. 2014 S. 1758-1762
Ganten, T. M.; Stauber, R.; Schott, E. et al.
Final analysis of overall survival per subgroups of HCC patients in the prospective, non-interventional INSIGHT study treated with sorafenibONCOLOGY RESEARCH AND TREATMENT. Bd. 37. 2014 S. 123-123
Al-Batran, S.; Kroening, H.; Hannig, C. V. et al.
FIRST-LINE CHEMOTHERAPIES FOR TREATMENT OF HER2-POSITIVE METASTATIC GASTRIC CANCER: UPDATED FINDINGS FROM THE GERMAN NON-INTERVENTIONAL STUDY HERMESANNALS OF ONCOLOGY. Bd. 25. 2014
Heinemann, Volker; von Weikersthal, Ludwig Fischer; Decker, Thomas et al.
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trialLANCET ONCOLOGY. Bd. 15. H. 10. 2014 S. 1065-1075
Vitali, Francesco; Hansen, Torsten; Kiesslich, Ralf et al.
Frequency and Characterization of Benign Lesions in Patients Undergoing Surgery for the Suspicion of Solid Pancreatic NeoplasmPANCREAS. Bd. 43. H. 8. 2014 S. 1329-1333
Sebode, Marcial; Lohse, Ansgar W.
Future Perspective: Immunomodulatory Therapy for Autoimmune HepatitisDIGESTIVE DISEASES. Bd. 32. H. 5. 2014 S. 502-506